Dr. Donald S. Marks
Claim this profileDonald S. Marks M.D., P.C.
Studies Alzheimer's Disease
Studies Mild Cognitive Impairment
10 reported clinical trials
10 drugs studied
Area of expertise
1Alzheimer's Disease
APOE
APOE ε4 positive
ApoE positive
2Mild Cognitive Impairment
APOE
ApoE positive
ApoE negative
Affiliated Hospitals
Donald S. Marks, MD., P.C.
Office Of Donald S. Marks, M.D., P.C.
Clinical Trials Donald S. Marks is currently running
CT1812
for Early Alzheimer's Disease
This is a multicenter randomized, double-blind, placebo-controlled Phase 2 study designed to evaluate the efficacy, safety, and tolerability of two doses of CT1812 compared to placebo in participants diagnosed with early Alzheimer's disease.
Recruiting0 awards Phase 2
Aducanumab
for Alzheimer's Disease
The primary objective of this study is to verify the clinical benefit of monthly doses of aducanumab in slowing cognitive and functional impairment as measured by changes in the Clinical Dementia Rating Scale Sum of Boxes (CDR-SB) score as compared with placebo in participants with early Alzheimer's disease.
Recruiting1 award Phase 31 criteria
More about Donald S. Marks
Clinical Trial Related1 year of experience running clinical trials · Led 10 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Donald S. Marks has experience with
- Placebo
- Donanemab
- Aducanumab
- ALZ-801
- Simufilam
- Syn-One Test
Breakdown of trials Donald S. Marks has run
Alzheimer's Disease
Mild Cognitive Impairment
Cognitive Impairment
Lewy Body Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Donald S. Marks specialize in?
Donald S. Marks focuses on Alzheimer's Disease and Mild Cognitive Impairment. In particular, much of their work with Alzheimer's Disease has involved APOE patients, or patients who are APOE ε4 positive.
Is Donald S. Marks currently recruiting for clinical trials?
Yes, Donald S. Marks is currently recruiting for 2 clinical trials in Plymouth Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Donald S. Marks has studied deeply?
Yes, Donald S. Marks has studied treatments such as Placebo, Donanemab, Aducanumab.
What is the best way to schedule an appointment with Donald S. Marks?
Apply for one of the trials that Donald S. Marks is conducting.
What is the office address of Donald S. Marks?
The office of Donald S. Marks is located at: Donald S. Marks M.D., P.C., Plymouth, Massachusetts 02360 United States. This is the address for their practice at the Donald S. Marks M.D., P.C..
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.